Scope: Diabetic retinopathy (DR) is a severe microvascular complication of diabetes. Previous clinical trials have shown that Compound Danshen Dripping Pill (CDDP) improves DR symptoms. However, the mechanism involved remains unclear.
INTRODUCTION
Diabetic retinopathy (DR) is one of the main complications of diabetes (Cheung et al., 2010) . It is the leading cause of blindness in patients aged 20-70 years. DR has become an important public health problem that affects more than 90% of diabetic patients. However, the current treatment for DR is for only advanced stages of the disease (Simo and Hernandez, 2009) . Drugs for early stage intervention in DR are limited.
Previously, scientists believed that DR was only a diabetic microvascular complication (AbuEl- Asrar et al., 2004) . However, increasing evidence shows that all retinal cells possess pathological changes from the early stages of diabetes (Lieth et al., 2000; Gardner et al., 2002) . Emerging evidence shows that neurodegeneration of the retinal neurodegeneration occurs before vascular lesions in patients with diabetes and becomes an early pathogenic event in DR (Barber et al., 2011) . Retinal neurodegeneration is an important event that induces microcirculatory abnormalities from the early stages of DR (Antonetti et al., 2012) .
Danshen (Salvia miltiorrhiza), a Chinese herb, can be used to treat blood stasis and improve blood circulation. In fact, Danshen has been used widely for treating angina pectoris, myocardial infarction, and stroke. Compound Danshen Dripping Pill (CDDP) is the first traditional Chinese drug that has been approved by the American FDA in phase II clinical trials for the treatment of cardiovascular disease (Luo et al., 2013) . The results of two clinical trials reveal that CDDP improves the symptoms of DR (Lian et al., 2015; Luo et al., 2015) . Animal experiments show that Danshen prevents oxidative stress in the eyes of diabetic rats (Yue et al., 2006) .
However, the exact mechanism of CDDP protection against DR remains unknown, particularly its neuroprotective mechanism. Our study was designed to utilize a whole transcriptome expression array to determine the important changes in gene expression that occur in the genomic profiles of early DR rats treated with CDDP. These results will help determine the potential protective mechanism of CDDP in patients with DR.
MATERIALS AND METHODS

Study Design and Animal Experiments
Five-week-old male SD rats (132.9 ± 10.3 g) were purchased from the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College (Beijing, China, SCXK-2014-0013) . All rats were maintained in cages at 24 ± 1 • C with the lights on from 6:00 a.m. to 6:00 p.m.
Control rats (n = 6) were fed a standard diet (kcal%: 10% fat, 20% protein, and 70% carbohydrate; 3.85 kcal/gm). Other rats (n = 18) were fed a high fat diet (kcal%: 45% fat, 20% protein, and 35% carbohydrate; 4.73 kcal/gm, Research Diet, New Brunswick, NJ, United States) for 4 weeks and were then injected intraperitoneally with streptozotocin (STZ, 30 mg/kg body weight) to induce diabetes (Guo et al., 2011; Ren et al., 2012; Davidson et al., 2014; Skovso, 2014; Zhang et al., 2016) . Fasting blood glucose levels were measured with a Bayer Contour TS glucometer (Bayer, Hamburg, Germany). Fasting blood glucose (FBG) levels >11.1 mmol/L were used to indicate the successful establishment of the type 2 diabetes mellitus (T2DM) model. Then, the diabetic rats were divided randomly into the following three groups: diabetic group (n = 6), low dose CDDP group (LCDDP, n = 6, 0.2 g/kg/d), and high dose CDDP (HCDDP, n = 6, 0.4 g/kg/d) group. CDDP was prepared by Tasly Pharmaceutical Group Co., Ltd. (Tianjin, China) and included Danshen (S. miltiorrhiza), notoginseng (Panax notoginseng) and borneol. CDDP was dosed via gastric gavage once daily for 12 weeks in the LCDDP group and HCDDP groups. The control and diabetic groups received 0.5% saline. After 12 weeks of treatment, the rats were sacrificed by cervical dislocation. The fresh eyeballs were immediately enucleated. The retinas were separated and stored at −80 • C to assess of RNA expression. The other eye was fixed in 4% paraformaldehyde for 24 h.
Electroretinography (ERG)
Electroretinography activity was assessed after the 12 weeks of treatment. Before the ERG tests, the rats were dark-adapted for 12 h and anesthetized intraperitoneally with 2% pentobarbital (50 mg/kg) under a dim red light. The pupils were fully dilated with topical 1% tropicamide (Santen Pharmaceutical Co., Ltd., Japan). A Ganzfeld stimulator with a flash intensity of 3 cd.s.m −2 generated light stimuli for the rats. Corneal electrodes recorded the flash ERG responses for both eyes. The negative and ground electrodes were placed in the subcutaneous space of the cheek and the tail, respectively. ERG signals were collected by an ESPION Console (Diagnosys LLC, Littleton, MA, United States). The ERG signals were amplified 20,000-fold, and filtered for 10-300 Hz using an amplifier. The amplitude of the ERG waves was measured as the difference between the maximum positive (stimulation) and negative (baseline) peaks. The oscillatory potentials (OPs) were measured as four to six wavelets from the rising phase of the b-wave. The magnitude of the OPs was calculated as the sum of the three major amplitudes.
Eyeball Histological Analysis
The eyeballs fixed in 4% paraformaldehyde were then cryoprotected in 30% sucrose, dehydrated in alcohol, and embedded in paraffin. Sections (5 µm) were stained with hematoxylin and eosin (H&E). Digital images were obtained using a Nikon Eclipse 90i digital microscope with the NIS-Elements 3.10 Image Analysis System (Nikon Instruments Inc., Lewisville, TX, United States). The total retinal thickness, inner nuclear layer (INL) thickness and outer nuclear layer (ONL) thickness were measured at 400× magnification. Two measurements were taken for each section at the two reference lines, which were 1 mm away from the optic nerve on both the superior and inferior sides. Cell numbers in the INL and the ONL were counted in the same region at 1000× magnification. All the cell nuclei within a fixed 25-µm column and centered with the 1-mm reference lines, were counted. The results from five sections per eye were averaged and there were six rats in each group.
RNA Isolation and Gene Expression Array
Total RNA from the rat retinas was extracted using a mirVana TM RNA Isolation Kit (Ambion, São Paulo, Brazil). Double-stranded cDNA was synthesized from RNA. Then cDNA was labeled with biotin. The biotinylated cDNA was purified, fragmented, and hybridized to an Affymetrix GeneChip Rat Gene 2.0 ST whole transcript-based array (Affymetrix Technologies, Santa Clara, CA, United States). After washing and staining, the microarrays were scanned using an Affymetrix Scanner 3000 7G (Santa Clara, CA, United States). Microarray signals were analyzed using Expression Console Software 1.41 Casp3, Caspase 3; Bax, BCL2 associated X; Npy, neuropeptide Y.
FIGURE 1 | The effect of CDDP on body weight (A) and blood glucose levels (B) in diabetic rats. LCDDP, low dose Compound Danshen Dripping Pill; HCDDP, high dose Compound Danshen Dripping Pill. n = 6 in each group. * * P < 0.01.
FIGURE 2 | The effect of CDDP on the amplitude of the a-waves (A), b-waves (B), and OPs (C) in diabetic rats. LCDDP, low dose Compound Danshen Dripping Pill; HCDDP, high dose Compound Danshen Dripping Pill. n = 6 in each group. * P < 0.05, * * P < 0.01.
(Affymetrix, Santa Clara, CA, United States). The final gene list contained only those proven sets with a P < 0.05 and fold change >1.5. For the interpretation and visualization of the data, Database for Annotation, Visualization, and Integrated Discovery (DAVID 1 ) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database were used. The array data have 1 http://david.abcc.ncifcrf.gov/ been submitted to the GEO database (GSE115866 2 , for reviewers only).
Quantitative Real-Time PCR
Total RNA from the retinas was used to synthesize cDNA with SuperScript II reverse transcriptase (Life Technologies, Carlsbad, Two measurements were taken from each section, at the two reference lines, which were 1 mm away from the optic nerve on both the superior and inferior sides. Cell numbers in the INL and ONL were counted in the same region at 1000× magnification. All the cell nuclei within a fixed 25-µm column and centered with the 1-mm reference lines, were counted. The results from five sections per eye were averaged. LCDDP, low dose Compound Danshen Dripping Pill; HCDDP, high dose of Compound Danshen Dripping pill; INL, inner nuclear layer; ONL, outer nuclear layer. The results from five sections per eye were averaged. n = 6 in each group. * P < 0.05, * * P < 0.01.
Frontiers in Physiology | www.frontiersin.orgCA, United States). Quantitative PCR was performed using gene-specific primers ( 
Apoptosis Assessment in the Retina
Apoptosis was evaluated with the TdT-mediated dUTP nick-end labeling (TUNEL) method. Briefly, paraffin-embedded sections were dewaxed, washed with PBS and incubated with Proteinase K for 20 min. After washing with PBS, 50 µL of reaction solution (TUNEL Apoptosis Detection Kit, Roche Applied Science, Mannheim, Germany) was added to each slide at 37 • C for 60 min in the dark. After washing, the sections were incubated with 3% hydrogen peroxide for 20 min. Then, 50 µL of Converter-POD (TUNEL Apoptosis Detection Kit, Roche Applied Science, Mannheim, Germany) was added to the sections at 37 • C for 30 min. Finally, a DAB Color Development Kit (ZSGB-BIO, Beijing, China) was used to stain the slides. Hematoxylin was used to stain the nuclei. The slides were analyzed using ImageJ Software (National Institutes of Health, Baltimore, MD, United States) at 400× magnification.
Data Analysis
The values are expressed as the mean ± SD. Differences among the groups were compared with one-way ANOVA followed by Turkey's post hoc test. Differences between two groups were compared with unpaired Student's t-test. For gene ontology (GO) and KEGG pathway analyses, Fisher's exact test was used. Differences were considered statistically significant for P-values <0.05. GraphPad Prism Software 5.0 (San Diego, CA, United States) was used for data analysis.
Ethics Statement
Procedures involving animals and their care were conducted in accordance with international and national law and policies (EU Directive 2010/63/EU for animal experiments, ARRIVE guidelines and the Basel Declaration including the 3R concept).
All procedures were performed with the approval of the Animal Care Committee of the Peking Union Medical Hospital Animal Ethics Committee (Project XHDW-2015 -0051, February 15, 2015 , and all efforts were made to minimize animal suffering.
RESULTS
The Effect of CDDP on Body Weight and FBG Levels in Diabetic Rats
The body weight was lower in the diabetic group than in the control group (P < 0.01, Figure 1A) . The CDDP groups also had comparable body weight to those of the diabetic group (P > 0.05, Figure 1A ). The diabetic group had higher plasma glucose levels than the control group (P < 0.01, Figure 1B ). Neither the low dose nor the high dose of CDDP decreased blood glucose levels in the diabetic rats (P > 0.05, Figure 1B ).
The Effect of CDDP on the ERG Results in Diabetic Rats
To evaluate the effect of CDDP on DR, full-field flash ERG was measured. The amplitudes of the a-waves (P < 0.01, Figure 2A) , b-waves (P < 0.01, Figure 2B ), and OPs were significantly reduced in diabetic rats (P < 0.01, Figure 2C ). Although CDDP did not moderate the amplitudes of the a-waves in diabetic rats (P > 0.05, Figure 2A) , it enhanced the amplitudes of the b-waves and OPs (P < 0.05, Figures 2B,C) . These results indicate that CDDP restored retina function in diabetic rats. 
The Effect of CDDP on Retinal Morphometry
The total retina thickness and the ONL thickness were lower in the diabetic rats than in the control rats (P < 0.01, Figures 3A,B,D) . The cell count in the ONL was also lower in diabetic rats than in the control rats (P < 0.01, Figures 3A,F) . CDDP increased the total retina thickness, ONL thickness and cell counts in the ONL (P < 0.05, Figures 3A,B,D,F ). There were no significant change among the four groups in INL thickness or the INL cell counts (P > 0.05, Figures 3A,C,E) .
Gene Array Analysis
To reveal the molecular mechanisms underlying in the retinal effects CDDP in diabetic rats, we performed a genome-wide expression profiling analysis on total RNA isolated from the retinas of the HCDDP group and the diabetic group (n = 3 in each group) (Hargadon, 2015; Funderburk et al., 2017 ; Gambara et al., 2017; Li et al., 2017) . We found that 262 genes were differentially expressed in the retinas of HCDDP-treated rats (fold change >1.5, P < 0.05). Of these genes, 116 genes were upregulated, 146 genes were downregulated. The differentially expressed genes were enriched in six pathways (P < 0.05, Table 2 ). The top five pathways of these genes were fat digestion and absorption, amyotrophic lateral sclerosis, pathway in cancer, apoptosis, and colorectal cancer. The top ten genes were related to significant biology processes (BPs) in the GO categories, including intracellular sequestering of iron ion, iron ion transport, embryo development, ending in birth, or egg hatching, negative regulation of cell proliferation, acute-phase response, axonogenesis, circadian rhythm, response to drug, and response to wounding (P < 0.01, Figure 4A and Table 3 ). String interaction analysis showed twelve genes that had more than five interactions with other differentially expressed genes, including Tp53 (tumor protein p53), Adrbk1 (G protein-coupled receptor kinase 2), Timp1 (TIMP metallopeptidase inhibitor 1), Bcl-2, Caspase 3 (Casp3), Apob (apolipoprotein B), IgG-2a (gamma-2a immunoglobulin heavy chain), Hip1r (huntingtin interacting protein 1 related), Hist2h4 (histone cluster 2 H4), Olr1512 (olfactory receptor 1512), Olr1743 (olfactory receptor 1743), and Olr441 (olfactory receptor 441, Figure 4B ).
Gene Expression in qPCR
Real-time quantitative PCR confirmed the results of the gene array. Bax and Casp3 levels increased significantly and TIMP1, Bcl-2, and neuropeptide Y (NPY) levels decreased in diabetic rats (P < 0.01, Figure 5) . CDDP mediated the expression of these genes in the rat retinas (P < 0.01, Figure 5 ).
Effect of CDDP on Retina Bcl-2 and Bax Expression in Diabetic Rats
Bcl-2-and Bax-positive cells were localized mainly in the INL.
Immunohistochemistry analyses showed that Bcl-2 expression in the retinas of diabetic rats decreased (P < 0.01, Figure 6 ). However, Bax expression increased in the diabetic retinas (P < 0.01, Figure 6 ). After 12 weeks of treatment, Bcl-2 expression increased and Bax expression decreased in both CDDP treatment groups (P < 0.05, Figure 6 ).
Effect of CDDP on Cell Apoptosis in the Diabetic Rat Retina
TdT-mediated dUTP nick-end labeling-positive cells were localized mainly in the ganglion cell layer (GCL) and INL. TUNEL analysis showed that cell apoptosis in the diabetic rats increased (P < 0.01, Figure 6 ). CDDP treatment reduced cell apoptosis in the diabetic rat retinas (P < 0.01, Figure 6 ).
DISCUSSION
In this study, we found that high-fat diet and STZ-induced diabetic rats had abnormal b-wave amplitudes and OPs, which indicated that the T2DM rat model had developed DR. Increasing evidence shows that diabetic patients also exhibit similar abnormalities in the early stages of DR (Holopigian et al., 1992; Shirao and Kawasaki, 1998) . Interestingly, in our study, we demonstrated for the first time that CDDP had beneficial effects on ERG results in diabetic rats. Without any effect on blood glucose level or body weight, CDDP restored the b-wave amplitude and OPs. These results indicate that CDDP may be an effective drug for treating of DR. Previously, two randomized, double-blind clinical trials showed that CDDP improves the symptoms of non-proliferative DR (NPDR) (Lian et al., 2015; Luo et al., 2015) . The current study is the first to provide evidence that CDDP prevents retinal neurodegeneration independent of blood glucose levels in diabetic rats. Moreover, we found that diabetic rats had thinner ONLs and fewer cells in the ONLs of the retinas. Previously, in other diabetic rodent models, researchers also found similar changes (Barber et al., 1998; Martin et al., 2004) . In our study, CDDP significantly improved the thickness of the entire retina and ONL and the cell count in the ONL in diabetic rat retinas. These results indicate that CDDP can delay the progression of DR in a rat model. To elucidate the mechanism by which CDDP mediates neuroprotection, we performed a whole genome expression array of the retinas in the CDDP-treated and diabetic groups. Our results showed that compared to those in the diabetic group, differentially expressed genes in the CDDP treatment groups were related mainly to the apoptosis pathway. From the TUNEL results, we also observed that the CDDP-treated groups had fewer TUNEL-positive retina cells than the untreated diabetic group. An increasing number of scientists believe that retinal cell apoptosis and reactive gliosis are basic pathological features of early DR (Simo and Hernandez, 2012) . Previous studies in human and animal models indicate that DR is associated with apoptosis (Barber et al., 1998; Kern et al., 2000) . Taken together, the cell apoptosis-inhibiting property of CDDP might be linked to retina neuroprotection in diabetic rats.
Next step, we searched the gene interaction of differentially expressed genes in the CDDP-treated groups compared to those in the diabetic group. String analysis showed that TIMP1, Bcl-2 and Casp3 were central in the gene interaction network. These genes are involved in apoptosis. Thus, based on the gene expression results, our study also showed that the mechanism of CDDP retinal neuroprotection involves retinal cell apoptosis. First, CDDP prevented the diabetes-induced TIMP1 reduction. TIMP1 and matrix metalloproteinases (MMPs) are important for cell-extracellular matrix (ECM) integrity in the retina (Akahane et al., 2004; German et al., 2008; Hansson et al., 2011) . These molecules remodel the ECM to regulate neural organization (Cornelius et al., 1995; Yamada et al., 2001 ). In addition, TIMP1 was found to inhibit apoptosis in neurons (Ashutosh et al., 2012) . A recent clinical trial and animal experiment also suggested that TIMP1 is significantly upregulated in retinal degeneration The results from five sections per eye were averaged. n = 6 in each group. * P < 0.05, * * P < 0.01. (Matsuo et al., 1998; Zeiss et al., 1998; Kim et al., 2014) . In addition to acting on MMPs (Murphy et al., 2002) , TIMP1 also significantly inhibits Bax activity and reduces ONL thinning in the early stages of DR (Kim et al., 2018) . Second, in our study, CDDP treatment also inhibited the abnormally high expression of Bax. These results indicate that the neuroprotective effect of CDDP on the diabetic rat retina is mediated by TIMP1 expression inhibition and increased Bax expression, which inhibit apoptosis in the diabetic retina. Bax belongs to the Bcl-family, which plays an important role in mitochondrial apoptosis (Brunelle and Letai, 2009) . In contrast, Bcl-2 is an apoptotic cell death blocker (Merry and Korsmeyer, 1997) . In our study, both immunohistochemistry and gene expression analyses revealed a significant increase in Bax expression and a reduction in Bcl-2 expression in the diabetic retina. A previous study also showed similar results (Oshitari and Roy, 2005; Kim et al., 2013) . Our results showed that CDDP reversed the changes in Bax and Bcl-2 expression. These results indicate that CDDP ameliorated retinal neural cell apoptosis. Caspases are a family of thiol proteases. They are important regulators of the apoptotic cascade and are enzymes induced by high glucose concentrations (Mohr et al., 2002) . In present study, we found that Casp3 expression was increased in diabetic rat retinas. These results are consistent with those of previous studies (Gao et al., 2017) . We also found that CDDP could inhibit Casp3 expression in the diabetic retina to inhibit apoptosis.
In addition, the present study found that CDDP restored the diminished NPY expression in diabetic rats. Retinal cells express NPY, particularly in neurons (Oh et al., 2002) . NPY plays an important role in the development (Prada Oliveira et al., 2003) , neuromodulation (D'Angelo and Brecha, 2004) , and neuroprotection (Koulu et al., 2004) of the retina. A genome-wide association study (GWAS) in a Finnish population showed that NPY gene polymorphisms are associated with increased incidence of DR (Niskanen et al., 2000; Koulu et al., 2004) . The gene can be used as a predictor for earlier DR onset (Jaakkola et al., 2006) . Thierry et al. (2015) found that NPY expression was reduced after 3 days of a high-fructose diet in rat models. In an oxygen-induced retinopathy mouse model, researchers also found that NPY expression was decreased (Schmid et al., 2012) . Our research provides evidence that CDDP could restore retinal NPY expression in diabetic rats.
CONCLUSION
In summary, we found therapeutic properties of CDDP for the prevention of DR. This is the first study to report that CDDP has retinal neuroprotective effects that are independent of blood glucose levels in diabetic rats. These CDDP-induced neuroprotective effects may be mediated by retinal cell apoptosis inhibition and increased NPY expression.
